{"id":"W4401354990","doi":"10.1016/j.esmoop.2024.103647","title":"Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"Eli Lilly Japan; Sirtex Medical; Ipsen; Kaohsiung Medical University Chung-Ho Memorial Hospital; Teijin Pharma; Japanese Society of Medical Oncology; European Society for Medical Oncology; Health Promotion Administration, Ministry of Health and Welfare; Kaohsiung Medical University; Chunghwa Telecom Laboratories; ReShape Lifesciences; Genentech; Veracyte; Astellas Pharma; Eisai; Fondazione Beretta; BeiGene; Handok; Les Laboratories Pierre Fabre; Pfizer; Incyte; Boehringer Ingelheim Japan; Taiho Pharmaceutical; Chugai Pharmaceutical; Abbott Japan; AstraZeneca; Invitae; Yuhan; Daiichi Sankyo Europe; Servier; Gilead Sciences; Halozyme; Exelixis; Sanofi; Relay Therapeutics; Amgen; Rakuten Medical; Celgene; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Biliary tract cancer; Cancer; Medicine; Biliary tract; Clinical Practice; General surgery; Internal medicine; Family medicine; Gemcitabine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003500948,0.0001747391,0.000420507,0.00003354393,0.0001032575,0.00005744736,0.0001293182,0.0000580893,0.00005643575],"category_scores_gemma":[0.000624511,0.00008710121,0.0001208229,0.0001319933,0.00009461061,0.0001869524,0.00008833929,0.0001045207,0.000002347974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006050808,"about_ca_system_score_gemma":0.0002749466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004825951,"about_ca_topic_score_gemma":0.002650353,"domain_scores_codex":[0.9988515,0.00004328138,0.0004140189,0.0003503583,0.0001754903,0.0001652861],"domain_scores_gemma":[0.9981272,0.0009517304,0.0001057003,0.0002876239,0.0004550132,0.00007278923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001680336,0.0004370262,0.6230867,0.00008306716,0.001540878,0.00002154721,0.00112083,7.673165e-7,6.036833e-7,0.00004477679,0.08004056,0.2919429],"study_design_scores_gemma":[0.003682803,0.001306047,0.6258607,0.00023729,0.001360041,0.000005202255,0.0006725125,0.00004005865,0.0000399755,0.00001129745,0.3666967,0.00008730283],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7849927,0.04913872,0.00009220452,0.1512204,0.002159335,0.00819217,0.0006139996,0.00008731822,0.003503127],"genre_scores_gemma":[0.9861943,0.007469326,0.001540898,0.002036148,0.0003621386,0.00120785,0.0000566146,0.00003625376,0.00109648],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2918556,"threshold_uncertainty_score":0.7295426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1414069728864935,"score_gpt":0.4450970365877709,"score_spread":0.3036900637012774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}